
Medidata Solutions
Founded Year
1999Stage
Acq - P2P | AcquiredTotal Raised
$21MValuation
$0000About Medidata Solutions
Medidata Solutions provides web-based technology that streamlines the design, planning, and management of key aspects of the clinical development process, including protocol development, investigator benchmarking and budgeting, contract research organization benchmarking and budgeting, and the capture, management, analysis, and reporting of clinical trial data. On October 29, 2019, Medidata Solutions was acquired by Dassault Systemes.
Missing: Medidata Solutions's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Medidata Solutions's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing Medidata Solutions
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Medidata Solutions in 2 CB Insights research briefs, most recently on Mar 28, 2022.
Expert Collections containing Medidata Solutions
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Medidata Solutions is included in 5 Expert Collections, including Clinical Trials Tech.
Clinical Trials Tech
341 items
Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.
Digital Health
12,660 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Telehealth
2,856 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Biopharma Tech
326 items
Precision Medicine Tech Market Map
160 items
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
Medidata Solutions Patents
Medidata Solutions has filed 65 patents.
The 3 most popular patent topics include:
- Clinical research
- Data management
- Discrete distributions

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
7/3/2017 | 11/8/2022 | Sensors, Autoimmune diseases, Neurological disorders, Inclinometers, Surface science | Grant |
Application Date | 7/3/2017 |
---|---|
Grant Date | 11/8/2022 |
Title | |
Related Topics | Sensors, Autoimmune diseases, Neurological disorders, Inclinometers, Surface science |
Status | Grant |
Latest Medidata Solutions News
Feb 21, 2023
02/21/2023 | 04:16pm EST Message : Marty Vanderploeg to Serve as Non-Executive Chair of the Board of Directors Workiva Inc. (NYSE: WK), the company powering transparent reporting for a better world, announced today that Julie Iskow, current President and Chief Operating Officer, has been appointed to succeed Marty Vanderploeg as Chief Executive Officer, effective April 1, 2023. Vanderploeg is stepping down as CEO, but will remain with the company in the role of Non-Executive Chair of the Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230221005356/en/ Workiva Inc. (NYSE: WK) Announces Julie Iskow as Chief Executive Officer (Photo: Business Wire) Current Board Chair and prospective Lead Independent Director Dave Mulcahy said, “The Board is delighted to appoint Julie Iskow to Chief Executive. She is a strong, respected, and values-driven leader with an impressive and proven track record of delivering consistent high-quality performance through her relentless commitment to our customers and to our people. Julie has played an instrumental role in Workiva’s success over the last three years. She is an engineer, technologist, and strategic operator, whose innovation-first mindset has created a differentiated product offering and sustainable rigor around Workiva’s platform and solutions. The Board is confident in Julie’s ability to lead Workiva through its next stage of growth.” Of her new role, Iskow said, “Workiva is one of the most relevant and innovative technology companies of our time. We have a transformative platform, unbridled potential, and an enduring foundation on which to build our future. I consider it a distinct privilege to succeed Marty and work with our incredibly talented team to move Workiva’s legacy forward into our next phase of growth and impact.” Mulcahy said, “We would like to thank Marty for his steadfast leadership. During his tenure, he transformed Workiva into the leading multi-solution platform company for assured integrated business reporting, serving 5,600 customers across the globe. Marty has been an exceptional leader for Workiva, championing an employee culture of progress, product innovation, customer focus, and achieving strong shareholder value. We look forward to working with him in his expanded Board leadership role.” “As a co-founder of Workiva, I have had the good fortune of working with a talented team for the past 15 years, five of those as CEO,” said Vanderploeg. “Now is the right time for me, and for Workiva, to make this change. Since day one of Julie’s arrival, she’s made our organization better. Julie has spent the past three years thoughtfully building and shaping our remarkable leadership team and operational strategy as we progress toward a long-term goal of $1 billion in revenue. I look forward to supporting her in my new role as Non-Executive Chair.” About Julie Iskow Julie Iskow joined Workiva in 2019 as EVP and Chief Operating Officer. She has extensive experience scaling enterprise SaaS companies with strong, profitable growth and has a robust background in product development and optimizing operations. Iskow was promoted to President and Chief Operating Officer in March 2022 and has been overseeing day-to-day operations with global responsibility for technology, product, sales, partners, marketing, services, and customer and partner experience. This transition allows her and the Workiva team to continue with their excellence in execution. Before joining Workiva, Iskow served as EVP and Chief Technology Officer at Medidata Solutions, creator of cutting-edge SaaS technology and analytics solutions for life sciences. Prior to Medidata, she was the Senior Vice President of Product Development and Chief Information Officer at WageWorks, a SaaS platform for consumer directed benefits solutions. Before WageWorks, she spent over a decade in engineering and technology leadership positions, responsible for automation and robotics software used in high-tech manufacturing. She currently serves on the board of directors of Workiva Inc. and Five9, a leading provider of cloud software for contact centers. She has a bachelor of science degree from the University of California, Berkeley and a master of science degree from the University of California, Davis. About Workiva Workiva Inc. (NYSE:WK) is on a mission to power transparent reporting for a better world. We build and deliver the world’s leading cloud platform for assured integrated reporting to meet stakeholder demands for action, transparency, and disclosure of financial and non-financial data. Workiva offers the only unified SaaS platform that brings customers’ financial reporting, Environmental, Social, and Governance (ESG), and Governance, Risk, and Compliance (GRC) together in a controlled, secure, audit-ready platform. Our platform simplifies the most complex reporting and disclosure challenges by streamlining processes, connecting data and teams, and ensuring consistency. Learn more at workiva.com. Follow Workiva on LinkedIn: www.linkedin.com/company/workiva Like Workiva on Facebook: www.facebook.com/workiva Follow Workiva on Twitter: www.twitter.com/workiva View source version on businesswire.com: https://www.businesswire.com/news/home/20230221005356/en/ © Business Wire 2023
Medidata Solutions Frequently Asked Questions (FAQ)
When was Medidata Solutions founded?
Medidata Solutions was founded in 1999.
Where is Medidata Solutions's headquarters?
Medidata Solutions's headquarters is located at 350 Hudson Street, New York.
What is Medidata Solutions's latest funding round?
Medidata Solutions's latest funding round is Acq - P2P.
How much did Medidata Solutions raise?
Medidata Solutions raised a total of $21M.
Who are the investors of Medidata Solutions?
Investors of Medidata Solutions include Dassault Systemes, Activate Venture Partners, Insight Partners, Stonehenge Capital, Lambda Funds and 5 more.
Who are Medidata Solutions's competitors?
Competitors of Medidata Solutions include maiData, JNPMEDI, Jeeva, Oncoshot, Unlearn, Clinical Research IO, Eclincloud, ThoughtSphere, Medable, Saama Technologies and 18 more.
Compare Medidata Solutions to Competitors

Medable is a decentralized clinical trial software company. The company's Software-as-a-Service (SaaS) cloud platform aims to provide a path to secure, HIPAA-compliant healthcare applications for researchers, startups, pharma, payers, and academia. This platform allows for supporting patient engagement clinical applications, storing personal health information, and complying with HIPAA and other regulations. Medable aims to enable patient-generated data to drive clinical research, healthcare delivery, and personalized and predictive medicine.
Castor EDC specializes in electronic data capture for medical research. It aims to take the clinical trial process which it describes as largely being offline and paper-based and digitizes it via software.

Clario offers endpoint technology solutions for clinical trials through a platform that enables pharmaceutical, biotech, and medical device partners to generate rich clinical evidence across all trial models: decentralized, hybrid, and site-based clinical trials. The company is the result of a merger between BioClinica and eResearchTechnology.

Saama Technologies is a clinical data and analytics company. Saama's unified, AI-driven clinical data analytics platform integrates, curates, and animates unlimited sources of structured, unstructured, and real-world data to deliver insights across all therapeutic areas. The platform gives real-time visibility into clinical data, enabling sponsors to file New Drug Applications (NDAs) more efficiently to bring drugs to market faster and at lower costs. Saama Technologies was founded in 1997 and is based in Campbell, California.

Medrio provides electronic data capture software for the process of clinical research. The platform supports phase I-IV trials, outcomes research, registries, retrospective chart reviews, and other clinical study needs.
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.